InvestorsHub Logo
icon url

1400

04/24/15 6:16 PM

#99063 RE: believer20 #99061

Aruda, Aspire blah blah blah all that matters is Kevetrin, Brilacidin and Prurisol and I have not heard or read one negative thing yet. The science wins out and Cellceutix gets it's day in the limelght...and then we're off to the races. It will happen if the former is true.

ECCMID, ASCO, Uplist, trials resumption all catalysts to turn us back up and all catalysts to find a wider audience. We need exposure!!!

Have a good weekend everybody.
icon url

TheDane

04/24/15 7:07 PM

#99068 RE: believer20 #99061

Nope. I've seen examples that belie that notion.